MEP17008A - Oksidekahidronaftalen modulatori hm74 - Google Patents

Oksidekahidronaftalen modulatori hm74

Info

Publication number
MEP17008A
MEP17008A MEP-170/08A MEP17008A MEP17008A ME P17008 A MEP17008 A ME P17008A ME P17008 A MEP17008 A ME P17008A ME P17008 A MEP17008 A ME P17008A
Authority
ME
Montenegro
Prior art keywords
oxidekahidron
modulatori
agreement
oxididealin
molecules
Prior art date
Application number
MEP-170/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Anne Minnich
Theresa Kuntzweiler
Haifeng Eishingdrelo
Michael Angelastro
Stephan Henke
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MEP17008A publication Critical patent/MEP17008A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
MEP-170/08A 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74 MEP17008A (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
RSP-2006/0472A RS20060472A (sr) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
MEP17008A true MEP17008A (hr) 2010-06-10

Family

ID=34910747

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-170/08A MEP17008A (hr) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Country Status (21)

Country Link
US (2) US7264937B2 (sr)
EP (1) EP1718293A1 (sr)
JP (1) JP2007526917A (sr)
KR (1) KR101145693B1 (sr)
CN (1) CN1929833A (sr)
AR (1) AR047708A1 (sr)
AU (1) AU2005216878B2 (sr)
BR (1) BRPI0507916A (sr)
CA (1) CA2556757C (sr)
CR (1) CR8537A (sr)
EC (1) ECSP066776A (sr)
IL (1) IL177106A (sr)
MA (1) MA28368A1 (sr)
ME (2) MEP17008A (sr)
NO (1) NO20064214L (sr)
RS (1) RS20060472A (sr)
RU (1) RU2006133539A (sr)
TN (1) TNSN06235A1 (sr)
TW (1) TWI354552B (sr)
WO (1) WO2005082352A1 (sr)
ZA (1) ZA200606687B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
KR101351209B1 (ko) 2004-12-03 2014-02-06 머크 샤프 앤드 돔 코포레이션 Ｃｂ1 길항제로서 치환된 피페라진
RU2008133381A (ru) * 2006-01-18 2010-02-27 Шеринг Корпорейшн (US) Модуляторы каннабиноидного рецептора
WO2008130616A2 (en) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines as cb1 modulators
CN101790521A (zh) * 2007-06-28 2010-07-28 英特维特国际股份有限公司 作为cb1拮抗剂的取代哌嗪
CN101796033A (zh) * 2007-06-28 2010-08-04 英特维特国际股份有限公司 作为cb1拮抗剂的取代的哌嗪

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1007563A4 (en) * 1997-06-12 2003-04-16 Smithkline Beecham Corp HM74A RECEPTOR
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
ECSP066776A (es) 2006-11-16
US20080045586A1 (en) 2008-02-21
BRPI0507916A (pt) 2007-07-10
EP1718293A1 (en) 2006-11-08
MA28368A1 (fr) 2006-12-01
NO20064214L (no) 2006-09-18
JP2007526917A (ja) 2007-09-20
TNSN06235A1 (en) 2007-12-03
US20050187263A1 (en) 2005-08-25
TWI354552B (en) 2011-12-21
CR8537A (es) 2007-03-05
CN1929833A (zh) 2007-03-14
AR047708A1 (es) 2006-02-08
CA2556757C (en) 2011-05-03
ZA200606687B (en) 2008-02-27
IL177106A0 (en) 2006-12-10
RS20060472A (sr) 2008-11-28
AU2005216878A1 (en) 2005-09-09
TW200539864A (en) 2005-12-16
RU2006133539A (ru) 2008-03-27
CA2556757A1 (en) 2005-09-09
AU2005216878B2 (en) 2010-06-17
ME00059B (me) 2010-06-10
US7264937B2 (en) 2007-09-04
WO2005082352A1 (en) 2005-09-09
KR101145693B1 (ko) 2012-05-25
IL177106A (en) 2012-03-29
KR20060127982A (ko) 2006-12-13

Similar Documents

Publication Publication Date Title
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
NO20071127L (no) Triazoloftalaziner
EA201100125A1 (ru) Производные пирролопиридинилпиримидин-2-иламина
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
ATE508190T1 (de) Mehrfachpromotor-expressionskassetten zurgleichzeitigen zuführung von rnai-agentien
EA201000549A1 (ru) Производные пиперидина и пиперазина
ATE430150T1 (de) 8-ä3-amino-piperidin-1-ylü-xanthine, deren herstellung und deren verwendung als dpp-iv hemmer
EA201300873A1 (ru) Производные 7-азаиндола
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
DE602008000754D1 (de) Tropanverbindungen
GB2436983A (en) Information access with usage-driven metadata feedback
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201070410A1 (ru) Твердые формы (s)-этил-2-амино-3-(4-(2-амино-6-((r)-1-(4-хлор-2-(3-метил-1h-пиразол-1-ил)фенил)-2,2,2-трифторэтокси)пиримидин-4-ил)фенил)пропаноата и способы их применения
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA201000550A1 (ru) Производные тиазола
MA32818B1 (fr) Arylpiperazines et leur emploi en tant qu'antagonistes de alpha2c
DE602004014190D1 (de) 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
EA201101097A1 (ru) Новые микробиоциды
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
MEP17008A (hr) Oksidekahidronaftalen modulatori hm74
MX2009006549A (es) Compuestos de amonio cuaternario con modo de accion novedoso para la proteccion de estructuras de madera.